NCT01436578View on ClinicalTrials.gov

Safety and Efficacy of Posaconazole Oral Suspension in Usual Practice in Korea (P08547)

CompletedOBSERVATIONAL
Enrollment

273

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Fungal Infections
Interventions
DRUG

Posaconazole oral suspension 40 mg/mL

Posaconazole oral suspension prescribed according to the current local label

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT01436578 - Safety and Efficacy of Posaconazole Oral Suspension in Usual Practice in Korea (P08547) | Biotech Hunter | Biotech Hunter